About Us

Archives






POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update

Posted: August 15, 2021 at 1:51 am


Strengthened the Company’s balance sheet by completing the business combination with Therapeutics Acquisition Corp (“RACA”), with gross proceeds from the transaction totaling approximately $286.7 million

View original post here:
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.